Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Kesimpta (ofatumumab) is a prescription medication for treating relapsing forms of multiple sclerosis (MS) in adults. It is a monoclonal antibody that targets CD20-positive B-cells, which are involved in the inflammation and damage seen in MS.
Kesimpta is available in a prefilled syringe form and is administered subcutaneously once monthly.
| Fact Table | |
| Formula |
C6480H10022N1742O2020S44 |
| License |
US FDA, EU EMA |
| Bioavailability |
70% |
| Legal status |
Rx-Only |
| Chemical Name |
Ofatumumab |
| Elimination half-life |
14 days |
| Dosage (Strength) |
- |
| Pregnancy |
Consult Doctor |
| Brands |
kesimpta |
| Protein binding |
Limited information |
| PubChem CID |
Not Available |
| MedlinePlus |
a621050 |
| ChEBI |
Not Available |
| ATC code |
L01FA02 |
| DrugBank |
DB06650 |
| KEGG |
D09314 |
| Routes of administration |
Subcutaneous |
The first injection of Kesimpta should be administered under the guidance of a licensed healthcare professional.
The usual regimen is as follows:
If a dose of Kesimpta is missed, it should be administered as soon as possible. However, if the missed dose is more than four weeks late, the next dose should be administered on the originally scheduled day.
The active ingredient in Kesimpta is ofatumumab.
There are many potential drug interactions, including:
Before starting Kesimpta, patients should be tested for hepatitis B virus infection and should be vaccinated against it if needed. Patients should also be screened for tuberculosis.
During treatment with Kesimpta, patients should be monitored for signs of infection, including fever, chills, cough, and sore throat.
Common adverse reactions include:
Kesimpta [package insert]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2020.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews